Abstract: The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
Type:
Application
Filed:
March 8, 2005
Publication date:
September 4, 2008
Applicants:
Inserm, Sandofi-Aventis
Inventors:
Sophie Lotersztajn, Ariane Mallat, Pascale Grenard, Boris Julien, Jeanne V. Nhieu